Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Accenture plcACN · Entity 2893 | Grp Chief Exec-Com, Med & Tech | July 05, 2018 | July 09, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Accenture plc
Report date July 05, 2018 · Filed July 09, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A ordinary sharesSEC Table I · non-derivative | Direct | 38,088 |
Reported balance
After 2018-07-05 transaction · row 1
1 source rowRow 1 · 2018-07-05 · Grant · Acquired 55 · Balance 38,088 F1: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. |
Filing footnotes · ownership attribution and instrument terms
F1: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2016 Filed Oct 6, 2016 20:39 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 152 | $118.11 | $17,952.72 |
DisclosureSEC source: 0001467373-16-001046 · wf-form4_147578634465970.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,030 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 21:10 UTC | Accenture plc ACN · Entity 2893 | SaleClass A ordinary shares | 1,200 | $121.79 | $146,146.44 |
DisclosureSEC source: 0001467373-16-001031 · wf-form4_147561539726292.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,878 F1 · price: The transaction was executed in multiple trades at prices ranging from $121.76 to $121.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 05, 2016 Filed Sep 7, 2016 11:19 UTC | Accenture plc ACN · Entity 2893 | GrantClass A ordinary shares | 156 | $115.75 | $18,057.02 |
DisclosureSEC source: 0001467373-16-001016 · wf-form4_147324716572195.xml · nonDerivative · entry 1 Sell Robert E · CIK 0001547931 · Grp Chief Exec-Com, Med & Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,078 F1 · shares: Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Leader Voluntary Equity Investment Program. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.